intranasal chadox1 ncov-19/azd1222 vaccination enhanced shedding of sars-cov-2 d614g in rhesus macaques.
intranasal chadox1 ncov-19/azd1222 vaccination enhanced shedding of sars-cov-2 d614g in rhesus macaques.
intranasal vaccination of rhesus macaques resulted in reduced shedding and a reduction in viral load in bronchoalveolar lavage and lower respiratory tract tissue.", "here we investigate whether intranasally administered chadox1 ncov-19 reduces shedding, using a sars-cov-2 virus with the d614g mutation in the spike protein.", "in conclusion, intranasal vaccination reduced shedding in two different sars-cov-2 animal models, justifying further investigation as a potential vaccination route for covid-19 vaccines."


































)